Form4insider filings, from the source

SEC Form 4 · accession 0001140361-15-023698

SANGAMO THERAPEUTICS, INC · SGMO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Dale G Ando
Officer — VP, Therapeutic Dev. & CMO
Period of report
Jun 5, 2015
Accepted (ET)
Jun 9, 2015 · 5:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001001233

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2,F3Jun 5, 2015M15,000$3.45A111,763D
Common StockF4,F2,F3Jun 5, 2015S15,000$12.2929D96,763D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Buy)F5$3.45Jun 5, 2015M15,000A—Dec 9, 2018Common Stock15,00050,798D

Explanation of responses